Stay updated with breaking news from Micro Labs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Marketing practices of pharma firms are under scrutiny after tax officials searched the premises of a drugmaker, and an association of medical representatives moved the Supreme Court alleging unethical marketing practices by drugmakers. Mint examines the issue.
Dolo 650 maker Micro Labs rejects allegations of Rs 1,000 crore worth freebies to doctors for prescribing it
Drug firm Micro Labs has termed the allegations that it offered freebies worth Rs 1,000 crore to doctors to promote its anti-inflammatory drug Dolo 650 as baseless.
Micro Labs spokesperson said that in some of the recent media reports it has been falsely and maliciously alleged that the company has been distributing freebies worth Rs 1,000 crore to promote Dolo 650 in one year.
Dolo 650 has been a brand leader for the last 20 years and we have been promoting the drug with a large field force, says Jayaraj Govindaraju, Executive VP, Micro Labs